Genome-wide approach to identify risk factors for therapy-related myeloid leukemia (Q46845159)

25 December 2017

title

Genome-wide approach to identify risk factors for therapy-related myeloid leukemia (English)

1 reference

25 December 2017

1 reference

Bogni A

1

1 reference

25 December 2017

Cheng C

2

1 reference

25 December 2017

Liu W

3

1 reference

25 December 2017

Yang W

4

1 reference

25 December 2017

Pfeffer J

5

1 reference

25 December 2017

Mukatira S

6

1 reference

25 December 2017

French D

7

1 reference

25 December 2017

Downing JR

8

1 reference

25 December 2017

Pui CH

9

1 reference

25 December 2017

Relling MV

10

1 reference

25 December 2017

publication date

1 February 2006

1 reference

25 December 2017

published in

Leukemia

1 reference

25 December 2017

volume

20

1 reference

25 December 2017

issue

2

1 reference

25 December 2017

page(s)

239-246

1 reference

25 December 2017

The secondary leukemias: challenges and research directions

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

Topoisomerase II inhibitor-related acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

Classification of pediatric acute lymphoblastic leukemia by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

Childhood acute lymphoblastic leukaemia--current status and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

Global gene expression as a function of germline genetic variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

Pharmacogenetics of outcome in children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

A DNA Polymorphism Discovery Resource for Research on Human Genetic Variation: Table 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

Computational comparison of two draft sequences of the human genome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

Detection of functional DNA motifs via statistical over-representation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

Association of CYP3A4 genotype with treatment-related leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

New light on Myc and Myb. Part II. Myb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

Cooperative binding of c-Myb and Pax-5 activates the RAG-2 promoter in immature B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

The V(D)J recombination activating gene, RAG-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

The RAG1 and RAG2 proteins establish the 12/23 rule in V(D)J recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

Developmentally controlled and tissue-specific expression of unrearranged VH gene segments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

Changes in histone acetylation are associated with differences in accessibility of V(H) gene segments to V-DJ recombination during B-cell ontogeny and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

The language of covalent histone modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

The t(1;12)(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

Gene expression profiling of pediatric acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

7 January 2021

Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

7 January 2021

Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

7 January 2021

Natural variation in human gene expression assessed in lymphoblastoid cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

7 January 2021

Lymphoid gene expression as a predictor of risk of secondary brain tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

7 January 2021

Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

7 January 2021

Etoposide induces chimeric Mll gene fusions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

7 January 2021

International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: overview report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

7 January 2021

Relationship between cytotoxicity and site-specific DNA recombination after in vitro exposure of leukemia cells to etoposide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404059

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404059

1 reference

25 December 2017

1 reference

25 December 2017